We are pleased to announce the first instalment of our 2024 Latin American regional program to address specific local challenges for physicians treating people with CML. We are starting this year's progam of three zoom-based Regional Discussion Groups on June 27th.
The Latin Amercan iCMLf Regional Discussion Groups offer a unique opportunity for CML physicians across Latin America to discuss case-related questions with International and Regional CML experts.
Meeting 1: Thursday June 27th
Meeting 1 Topics:
- A debate - Treatment Free Remission vs Dose-reduction as a pathway to stopping therapy
Registration now closed
Recording of the session available to watch here.
Meeting 2: Thursday August 8th
Meeting 2 Topics:
- Tyrosine kinase inhibitor (TKI) choice and sequencing of treatment in a world of increasing options
- Managing the chronic effects of TKI treatment
Meeting 3: Thursday September 12th
Meeting 3 Topics:
-
2023 ELN Laboratory Recommendations – challenges in low- and middle-income countries
Addressing key questions and issues for Latin America, including:
-
- BCR::ABL1 testing – when and how and monitoring
- BCR::ABL1 mutation testing – when and how
- Establishing high-quality laboratories when resources are limited
Timings for all meetings - 1-1.5 hours on Zoom beginning at:
-
Mexico City, Mexico. 1700
-
Bogota, Colombia. 1800
-
Santiago, Chile. 1900 (meeting 3, 2000)
-
Buenos Aires, Argentina. 2000
-
Rio de Janiero, Brazil. 2000
If you’re a physician treating people with CML in Latin America, we’d love for you to join us to expand your knowledge, connect with like-minded professionals and foster further collaboration in the field of CML.
Supported by a grant from Novartis.